hemp + health
hemp + health
Cannabidiol (CBD) is a hemp derivative used to treat a variety of common health issues without the euphoric high of THC.
Alzheimer’s Disease Anti-inflammatory, antioxidant, antiapoptotic; in vitro and in vivo models of Aβ-evoked neuroinflammatory and neurodegenerative responses. |
Anxiety Reduction of muscular tension, restlessness, fatigue, problems in concentration, improvement of social interactions in rodent models of anxiety, and stress; reduced social anxiety in patients. |
Cancer Antiproliferative and anti-invasive actions in a large range of cancer types; induction of autophagy-mediated cancer cell death; chemo-preventive effects. |
Cardiovascular Diseases |
Depression Anti-depressant effect in a genetic rodent model of depression. |
Diabetic Complications Attenuation of fibrosis and myocardial dysfunction. |
Huntington’s Disease Neuroprotective and antioxidant in mice transgenic models; no significant clinically important differences in patients. |
Hypoxia-ischemia Injury Short term neuroprotective effects; inhibition of excitotoxicity, oxidative stress and inflammation in vitro and in rodent models. |
Infection Activity against methicillin-resistant Staphylococcus aureus. |
Inflammatory Bowel and Crohn’s Diseases Inhibition of macrophage recruitment and TNF-α secretion in vivo and ex vivo; reduction in disease activity index in Crohn’s patients. |
Inflammatory Diseases Anti-inflammatory properties in several in vitro and in vivo models; inhibition of inflammatory cytokines and pathways. |
Multiple Sclerosis Improved signs of EAE in mice, anti-inflammatory and immunomodulatory properties. |
Nausea Suppression of nausea and conditioned gaping in rats. |
Pain Analgesic effect in patients with neuropathic pain resistant to other treatments. |
Parkinson’s Disease Attenuation of the dopaminergic impairment in vivo; neuro-protection; improvement of psychiatric rating and reduction of agitation, nightmare and aggressive behavior in patients. |
Psychosis Attenuation of the behavioral and glial changes in animal models of schizophrenia; anti-psychotic properties on ketamine-induced symptoms. |
Rheumatoid Arthritis Inhibition of TNF-α in an animal model. |
The above information is adapted from a 2017 study by the World Health Organization (WHO).
Download the full report here.